Advanced Cardiovascular Systems, Inc. v. C.R. Bard, Inc.

144 F.R.D. 372, 92 Daily Journal DAR 15137, 25 U.S.P.Q. 2d (BNA) 1354, 1992 U.S. Dist. LEXIS 16895, 1992 WL 321375
CourtDistrict Court, N.D. California
DecidedOctober 5, 1992
DocketNo. C90-0503 FMS (WDB)
StatusPublished
Cited by15 cases

This text of 144 F.R.D. 372 (Advanced Cardiovascular Systems, Inc. v. C.R. Bard, Inc.) is published on Counsel Stack Legal Research, covering District Court, N.D. California primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Advanced Cardiovascular Systems, Inc. v. C.R. Bard, Inc., 144 F.R.D. 372, 92 Daily Journal DAR 15137, 25 U.S.P.Q. 2d (BNA) 1354, 1992 U.S. Dist. LEXIS 16895, 1992 WL 321375 (N.D. Cal. 1992).

Opinion

OPINION AND ORDER RE MOTION TO COMPEL DISCOVERY

BACKGROUND

BRAZIL, United States Magistrate Judge.

We address here defendant C.R. Bard’s motion to compel (1) disclosure of communications between inventors and their patent counsel made in anticipation of filing the application of the patent in issue and (2) testimony by inventors and their patent counsel setting forth directly their understanding of several key technical phrases used in the patent claims.

The principal purpose of defendant’s motion is to compel both the inventors and their patent counsel to disclose communications that preceded and accompanied the drafting by counsel of the application for the patent in suit and that occurred in connection with a subsequent reexamination proceeding. At least some of these communications, according to defendant, involved primarily or exclusively technical information. Drs. John B. Simpson and Edward W. Robert were the inventors of angioplasty balloon catheters described and claimed in United States Patent No. 4,323,-071 (the “Simpson-Robert Patent”). Harold C. Hohbach is the patent lawyer who drafted the initial patent application. Edward J. Lynch is the lawyer who represented the inventors in the re-examination.

Plaintiff asserts that the attorney-client privilege protects the disputed communications from discovery. While their dispute reaches other communications from inventors to patent counsel, defendant seems primarily interested in learning what the inventors told their lawyers about the meaning of several key phrases that eventually appeared in the patent claims: “integral,” “formed integral therewith,” “formed therewith,” and “formed therein.” Plaintiff insists that the attorney-client privilege protects from discovery the private communications from inventor to patent counsel about the meaning of these phrases.

A second dispute between the parties revolves around plaintiff’s refusal to permit the inventors to testify about their understanding of the meaning of these same key phrases. Plaintiff opposes defendant’s discovery of these understandings on the grounds that such questions impermissibly require the inventors to articulate “conclusions of law.”

For the reasons set forth below, we hereby DENY that part of defendant’s motion that seeks disclosure of communication by the inventors to their patent attorneys. We hereby GRANT that part of defendant’s motion that requests us to order the inventors to disclose their understanding of terms used in the patent claims.

PRIVATE COMMUNICATIONS IN ANTICIPATION OF FILING THE PATENT APPLICATION

The core issue raised by defendant’s motion to compel is this: should the attorney-client privilege presumptively attach to communications that are made in private between an inventor and his or her patent attorney prefatory to the filing of an application for a patent?

The undersigned addressed this question in passing in a published opinion several years ago. See Hewlett-Packard Co. v. Bausch & Lomb, Inc., 116 F.R.D. 533, 542 [374]*374(N.D.Cal.1987). That opinion reflected no awareness that there was then, and remains today, a clear division of authority on this important issue. Apparently ignorant of the line of cases associated most visibly with Knogo Corp. v. United States, 213 U.S.P.Q. 936 (Ct.C1.1980), this court accepted the rulings in Jack Winter, Inc,, v. Koratron Co., 54 F.R.D. 44, 46-47 (N.D.Cal.1971) and Hercules Inc. v. Exxon Corp., 434 F.Supp. 136, 147-148 (D.Del. 1977), that the attorney-client privilege generally should not protect communications from inventors to their lawyers when the communications consist largely of technical information counsel would need in preparing an application for a patent.

Two rationales informed the rulings in Jack Winter and Hercules. One was that an attorney who was using technical information to prepare a patent application was primarily providing a business service rather than offering legal advice or providing legal services. Jack Winter, 54 F.R.D. at 47; Hercules, 434 F.Supp. at 147. The second rationale was that an inventor who provided counsel with technical information in connection with an anticipated application for a patent would expect the attorney to pass that information along to the United States Patent and Trademark Office (the “PTO”) (in part because the inventor would expect his application to contain technical information and in part because the inventor was assumed to understand that he and his counsel had a legal obligation of candor and full disclosure to the PTO). It followed, according to these courts, that the inventor in this setting would have no expectation that the information would remain confidential. Under this second rationale, counsel is assumed to serve as little more than a conduit (from inventor to PTO) for technical information. This assumed absence of an expectation of confidentiality was deemed fatal to a claim of privilege. Jack Winter, 54 F.R.D. at 47; Hercules, 434 F.Supp. at 147.

Constrained to rethink these issues in order to rule on defendant’s motion in the case at bar, and having been made aware by counsel for plaintiff of the well-reasoned competing line of authority best reflected in Knogo, supra, this court now reverses that portion of its earlier opinion that accepted the Jack Winter line of authority. Having considered the matter in greater depth, and having read all the relevant eases that we could find, we now reject the notion that the attorney-client privilege should not attach, presumptively, to private communications from inventor to lawyer that consist primarily of technical information related to an anticipated patent application.

Before explaining the principal bases for this reversal, we emphasize some important related points. First, what the privilege presumptively protects from discovery is specific communications between client and counsel, not the relevant underlying facts, data or information. Thus, the kind of information that the Jack Winter and Hercules courts were concerned about making available to opposing parties and to the trier of fact (“technical information such as the results of research, tests, and experiments”)1 will remain available, even if certain communications which include that information are presumptively privileged. In other words, opposing parties will remain free to discover, directly from the inventor, all the technical information the inventor had about the invention, all the results of tests the inventor performed, or had performed, all the documents related to experiments with the invention, everything the inventor knew about prior art, etc. The effect of the privilege only would be to block access to that kind of information indirectly, by blocking access to the private communications between inventor and patent lawyer.

Second, the view once held by several courts, see, e.g., McNeil-PPC, Inc. v. Procter & Gamble Co., 136 F.R.D. 666, 669-70 (DC Dist.Colo.1991);2 Howes v. [375]*375Medical Components Inc., 1 U.S.P.Q.2d 1511, 1512 (E.D.Pa.1988); Ashland Oil Inc. v. Delta Oil Products Corp., 209 U.S.P.Q. 151, 152-53 (E.D.Wis.1979); Burlington Industries v. Exxon Corp., 65 F.R.D. 26, 39 (D.Md.1974); Jack Winter, Inc. v. Koratron Co., 54 F.R.D.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Allen v. Purss
D. Oregon, 2022
Ropes & Gray LLP v. Jalbert
910 N.E.2d 330 (Massachusetts Supreme Judicial Court, 2009)
Probert v. Clorox Co.
258 F.R.D. 491 (D. Utah, 2009)
Hynix Semiconductor Inc. v. Rambus Inc.
591 F. Supp. 2d 1038 (N.D. California, 2006)
McCook Metals L.L.C. v. Alcoa Inc.
192 F.R.D. 242 (N.D. Illinois, 2000)
Exxon Research & Engineering Co. v. United States
44 Fed. Cl. 597 (Federal Claims, 1999)
Ryobi North America, Inc. v. Union Elec. Co., Inc.
7 F. Supp. 2d 1019 (E.D. Missouri, 1998)
CellNet Data Systems, Inc. v. Itron, Inc.
178 F.R.D. 529 (N.D. California, 1998)
Asyst Technologies, Inc. v. Empak, Inc.
962 F. Supp. 1241 (N.D. California, 1997)
John Labatt Ltd. v. Molson Breweries
898 F. Supp. 471 (E.D. Michigan, 1995)
Rohm & Haas Co. v. Brotech Corp.
815 F. Supp. 793 (D. Delaware, 1993)
Laitram Corp. v. Hewlett-Packard Co.
827 F. Supp. 1242 (E.D. Louisiana, 1993)

Cite This Page — Counsel Stack

Bluebook (online)
144 F.R.D. 372, 92 Daily Journal DAR 15137, 25 U.S.P.Q. 2d (BNA) 1354, 1992 U.S. Dist. LEXIS 16895, 1992 WL 321375, Counsel Stack Legal Research, https://law.counselstack.com/opinion/advanced-cardiovascular-systems-inc-v-cr-bard-inc-cand-1992.